Effect of granulocyte macrophage colony-stimulating factor in a patient with benign systemic mastocytosis
โ Scribed by T. Zuberbier; P. Welker; J. Grabbe; B.M. Henz
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 651 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We previously established 2 lung cancer cell lines, OKaโCโ1 and MIโ4, which constitutively produce an abundant dose of granulocyteโcolony stimulating factor (GโCSF) and granulocyte macrophageโcolony stimulating factor (GMโCSF). Many other cases with GโCSF or GMโCSF producing tumors have
GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of